CEA – MMab

Cea Mmab

IHC of CEA on an FFPE Colon Adenocarcinoma Tissue

Specification Sheets
Safety Data Sheet


Intended Use For In Vitro Diagnostic Use
Summary and Explanation Carcinoembryonic antigen (CEA) is a glycoprotein involved in cell adhesion. It is normally produced during fetal development, but the production of CEA stops before birth. Therefore, it is not usually present in the blood of healthy adults, although levels are raised in heavy smokers. CEA is synthesized during development in the fetal gut, and is re-expressed in increased amounts in Intestinal Carcinomas and several other tumors. CEA is employed essentially as a tool to assist in the distinction between Adenocarcinoma and Malignant Mesotheliomas of the epithelial type, along with other markers for mucosubstances such as Leu M1 and Ber-EP4. Another suggested use of CEA is the immunophenotyping of various Metastatic Adenocarcinomas as a means of identifying their origin.
Antibody Type Mouse Monoclonal Clone BSB-13
Isotype IgG1/K Reactivity Paraffin, Frozen
Localization Cytoplasmic Control Colon, Colon Adenocarcinoma
Presentation Carcinoembryonic Antigen is a mouse monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH 7.5, containing BSA and sodium azide as a preservative.
Catalog No. Antibody Type Dilution Volume/QTY
BSB 5337 Prediluted Ready-To-Use 3.0 ml
BSB 5338 Prediluted Ready-To-Use 7.0 ml
BSB 5339 Prediluted Ready-To-Use 15.0 ml
BSB 5340 Concentrated 1:250-1:1000 0.1 ml
BSB 5341 Concentrated 1:250-1:1000 0.5 ml
BSB 5342 Concentrated 1:250-1:1000 1.0 ml
BSB 5343 Control Slides 5
Note: For concentrated antibodies, please centrifuge prior to use to ensure recovery of all product.

Related products

Skip to content